Editorial: Metabolic reprogramming in breast cancer

Front Oncol. 2022 Nov 10:12:1081171. doi: 10.3389/fonc.2022.1081171. eCollection 2022.

Cristian Scatena^{1

2}, Antonio Giuseppe Naccarato^{1

2}, Bela Ozsvari³, Domenica Scumaci⁴

¹ Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
² Department of Laboratory Medicine, Pisa University Hospital, Anatomia Patologica 1 Universitaria, Pisa, Italy.
³ Translational Medicine, School of Science, Engineering and the Environment (SEE), University of Salford, Greater Manchester, United Kingdom.
⁴ Research Center on Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy.

No abstract available

Keywords: breast cancer; breast cancer treatment; metabolic reprogramming; metabolic therapy; resistance mechanisms.

Publication types